Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Queen Mary University of London · Royal Free London NHS Foundation Trust · +17 more institutions
Indexed incrossrefpubmed
Abstract
Renal cancer is the 14th most common malignancy worldwide, with >430 000 new cases diagnosed in 2020.1 The incidence varies geographically, with higher incidence in Europe and North America. Renal cell carcinoma (RCC) accounts for ∼90% of all renal cancers.1-3
Citation impact
281
total citations
- FWCI
- 105.02
- Percentile
- 100%
- References
- 80
Citations per year
Authors
16- TPT. PowlesCorresponding
Queen Mary University of London, Royal Free London NHS Foundation Trust
- LALaurence Albigès
Université Paris-Saclay, Institut Gustave Roussy
- ABAxel Bex
University College London, Royal Free London NHS Foundation Trust, The Netherlands Cancer Institute
- ÉCÉva Compérat
Vienna General Hospital, Medical University of Vienna
- VGViktor Grünwald
Topics & keywords
Topics
Keywords
- Medicine
- Guideline
- Renal cell carcinoma
- Oncology
- Clinical Practice
- Carcinoma
- Internal medicine
- Family medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.